CLB (Core Laboratories) Total Stockholders Equity: $272.7 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CLB Core Laboratories Inc CLB
62 GF Score
Price $10.95
GF Value $17.18
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Core Laboratories Total Stockholders Equity?

Core Laboratories CLB -2.41% 62 Total Stockholders Equity is $272.7 Mil as of Jun. 2026. GuruFocus rates CLB with a GF Score™ of 62/100 and a GF Value™ of $17.18 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Core Laboratories's Total Stockholders Equity for the quarter that ended in Jun. 2026 was $272.7 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Core Laboratories's Book Value per Share for the quarter that ended in Jun. 2026 was $5.94. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Core Laboratories's Debt-to-Equity for the quarter that ended in Jun. 2026 was 0.61.

Core Laboratories  (NYSE:CLB) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Core Laboratories's Book Value per Share for the quarter that ended in Jun. 2026 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(272.669-0)/45.884
=5.94

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Core Laboratories's Debt-to-Equity for the quarter that ended in Jun. 2026 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(11.94 + 153.175) / 272.669
=0.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Core Laboratories Total Stockholders Equity Related Terms

Core Laboratories Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Core Laboratories's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Core Laboratories Total Stockholders Equity Chart

Core Laboratories Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 156.45 184.26 224.82 246.57 265.99

Core Laboratories Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 261.28 271.35 265.99 268.89 272.67
CLB
62GF Score
Core Laboratories Inc CLB
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of $272.7 Mil mean?
Core Laboratories (CLB) has a Total Stockholders Equity of $272.7 Mil as of Jun. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Core Laboratories and its competitors.
Is Core Laboratories' Total Stockholders Equity too high?
Core Laboratories' current Total Stockholders Equity is $272.7 Mil. Overall, Core Laboratories has a GF Score™ of 62/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Core Laboratories' Total Stockholders Equity compare to EROK and OIS?
Core Laboratories' Total Stockholders Equity of $272.7 Mil can be compared against companies in the Oil & Gas industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for an Oil & Gas company?
A good Total Stockholders Equity depends on the Oil & Gas industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Core Laboratories and its competitors. Core Laboratories's current Total Stockholders Equity is $272.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Core Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Core Laboratories (CLB) is currently considered Significantly Undervalued. The stock's GF Value™ is $17.18, compared to a current price of $10.95 — trading 36.3% below its estimated fair value. The current Total Stockholders Equity is $272.7 Mil. Core Laboratories' overall GF Score™ is 62/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Core Laboratories (CLB), the current Total Stockholders Equity is $272.7 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Core Laboratories (CLB) Overvalued in 2026?

Based on GuruFocus' analysis, Core Laboratories stock appears to be undervalued. The current stock price of $10.95 is trading 36.3% below its estimated GF Value™ of $17.18. GuruFocus considers Core Laboratories to be Significantly Undervalued.

Key valuation signals for CLB:

  • Total Stockholders Equity: $272.7 Mil
  • GF Value™: $17.18 vs. price of $10.95 (36.3% below fair value)
  • GF Score™: 62/100 with 3 warning signs

No single metric tells the full story. See the CLB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Core Laboratories Business Description

Industry EnergyOil & Gas
Other Exchanges HJ1:Germany
Address 6316 Windfern Road, Houston, TX, USA, 77040
Core Laboratories Inc is a providers of proprietary and patented reservoir description and production enhancement services and products to the oil and gas industry, through client relationships. The company operates its business in two segments; Reservoir Description, and Production Enhancement. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services. The company generates majority of its revenue from Reservoir Description segment.
62GF Score

Get the complete analysis for CLB

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.95
Price
$17.18
GF Value